IVERMECTIN and HERPES - 20 Quick Testimonials
An online blog post titled “Ivermectin and Herpes – 20 Quick Testimonials” compiles twenty personal accounts claiming the antiparasitic drug ivermectin alleviates herpes simplex outbreaks. The piece provides no clinical data, dosage information, or peer‑reviewed evidence to support the claims. Ivermectin is FDA‑approved for treating certain parasitic infections, while standard herpes therapy relies on antiviral medications such as acyclovir. The post reflects a broader trend of off‑label drug promotion amid misinformation.
Health Care Is the Largest Industry in the US by Total Spending and Employment
U.S. health care spending reached $5.3 trillion in 2024, making it the nation’s largest industry by both total outlays and employment. The growth is driven primarily by increased utilization of medical services rather than price inflation, with per‑capita spending climbing to...
Trinity Launches InsightsEDGE™ | Digital Twins — Generative AI Unlocks Always-On Intelligence for Life Sciences Commercial Teams
Trinity announced the general availability of InsightsEDGE | Digital Twins, an AI‑powered platform that creates interactive virtual replicas of healthcare professionals, patients, and payers. The solution leverages Trinity’s 30‑year research pedigree and its proprietary Weave data fabric to continuously ingest claims, EMR,...
Corcept Presents Complete Data From Pivotal ROSELLA Trial in SGO Late-Breaker with Simultaneous Publication in The Lancet: Lifyorli™ (Relacorilant) Plus...
Corcept Therapeutics presented final overall survival results from the phase 3 ROSELLA trial, showing that Lifyorli™ (relacorilant) combined with nab‑paclitaxel cuts the risk of death by 35 percent and adds 4.1 months to median survival versus chemotherapy alone. The regimen met both overall...
NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference
NeuroPace, the maker of the RNS System for drug‑resistant epilepsy, announced that its executive team will present at the 25th Annual Needham Virtual Healthcare Conference on April 14, 2026. The session will be streamed live and a replay will be available...
Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting
Covalon Technologies Ltd. announced its participation in the Infusion Nurses Society (INS) 2026 Annual Meeting in Louisville, Kentucky, from April 11‑14. The company will showcase its VALGuard Vascular Access Line Guard and CovaClear IV Cover dressings, emphasizing solutions that protect...
How Patient Portal Message Volume Drives Physician Burnout
Patient portals, once touted as a convenience, now generate a flood of after‑hours messages that physicians must triage without compensation. A 2025 JAMA Internal Medicine study of 280,000 outpatient doctors shows portal volume surged during the pandemic and remains elevated,...
Get Covered Illinois Announces New Tax Time Easy Enrollment Program; Pregnancy Now Qualifies for Special Enrollment Period
Get Covered Illinois has launched a Tax Time Easy Enrollment program that lets Illinois tax filers add a health‑insurance request directly on the IL‑1040 form. By checking the box on line 42, the Department of Revenue shares household income and size...
The Second Victim Label Ignores Patient Safety Reality
Timothy Lesaca argues that the "second victim" label, coined two decades ago to acknowledge clinicians’ emotional trauma after patient harm, now distracts from systemic safety failures. He contends that focusing on individual support—counseling, resilience training—ignores root causes such as understaffing...
The Nurse Who Almost Quit, and Why Her Story Is the Future of Healthcare
Ian Khan warns that the nursing profession faces a structural crisis, with a global shortfall of roughly 5.8 million nurses and an expected exodus of over one million U.S. registered nurses by 2030. Burnout, staffing gaps, and a 40% turnover rate...
Imeglimin. A New and Novel Drug Thats Better than Metformin
Imeglimin, a novel oral antidiabetic approved in Japan and the EU, improves mitochondrial bioenergetics and reduces HbA1c more effectively than metformin. Its renal excretion bypasses the CYP3A4 pathway, eliminating pharmacokinetic conflicts with rapamycin, an mTOR inhibitor used in longevity protocols....
Do ASC’s Have an Unfair Advantage over Inpatient Care?
A large matched‑cohort analysis of 8,342 single‑level ALIF and LLIF cases performed in ambulatory surgery centers (ASCs) versus hospitals (2010‑2022) found outpatient procedures had lower intra‑operative and 90‑day complication rates, fewer emergency‑department visits, reduced readmissions, and superior five‑year revision‑free survival....
RW-ApoB -- Superior Metric For Lipid Related CVD Risk --- Using Lp(a), ApoB, and Triglycerides
Researchers introduced risk‑weighted apoB (RW‑ApoB), a composite metric that integrates LDL‑C, triglyceride‑rich remnants, and lipoprotein (a) to better predict coronary heart disease. Using data from 285,060 UK Biobank participants not on lipid‑lowering therapy, RW‑ApoB demonstrated higher CHD prediction accuracy than traditional...
Influenza Vaccination Reduces Cardiovascular Risk Following Infection
A new Danish register‑based self‑controlled case series spanning 2014‑2025 shows that influenza infection triggers a sharp, short‑lived surge in acute myocardial infarction and stroke, especially within the first three days. Prior influenza vaccination cuts the excess cardiovascular risk dramatically, with...
ISG to Study Medical Device Digital Service Providers
Information Services Group (ISG) announced a new Provider Lens® research series called Medical Device Digital Services, scheduled for release in October 2026. The study surveyed over 100 service providers that help medical‑device manufacturers embed AI, cloud, and IoT capabilities into their...
Independent Medical Alliance Named Liaison to CDC’s ACIP Vaccine Committee
The Independent Medical Alliance (IMA) has secured a historic liaison seat on the CDC’s Advisory Committee on Immunization Practices (ACIP), the first time a national coalition of independent physicians will directly contribute to vaccine policy. IMA represents over 12,000 independent...
AI Holds Potential to Improve Geriatric Medicine
A December 2025 journal review confirms that artificial intelligence is reshaping geriatric medicine, from early disease detection to personalized treatment and administrative efficiency. AI‑driven pattern recognition can flag dementia biomarkers, predict drug interactions, and tailor rehabilitation programs via wearables. Virtual...
Why Streamlining Support Is Key to Long-Term Adherence
In a final interview with Pharmaceutical Commerce, ConnectiveRx chief commercial officer Laura Blair argues that simplifying patient‑support workflows is essential for sustaining long‑term adherence to specialty therapies. She calls for “cleaner” digital tools that embed enrollment and diagnostic assistance directly...
Why Kidney Disease Innovation Is a Tale of Two Cities — and What It Would Take to Change That with...
John Butler, CEO of Akebia Therapeutics, explained the stark contrast between rapid innovation in rare kidney diseases and the near‑absence of new dialysis therapies, blaming regulatory uncertainty and a Medicare bundle that discourages drug development. FDA clarity on endpoints sparked...
MediStreams Achieves Clean SOC 2 Type II Certification, Strengthening Security in Healthcare Revenue Cycle Management and Payment Automation
MediStreams announced it has received a clean SOC 2 Type II audit for the full 2025 calendar year, covering Security, Availability, and Processing Integrity. The unqualified opinion was issued by independent CPA firm Aprio LLP after a year‑long assessment of its payment‑posting...
CT Senate Votes to Expand Psychedelic Treatment Program
The Connecticut Senate unanimously approved Senate Bill 191, expanding Yale’s psychedelic therapy pilot to include first responders, EMTs, and frontline healthcare workers alongside veterans. The legislation removes a provision that would have ended the study if the FDA approved psilocybin,...
Zeto New Wave EEG System Wins FDA Clearance For At-Home Brain Monitoring
Zeto announced FDA 510(k) clearance for its New Wave EEG system, the company’s third FDA‑approved neuro‑diagnostic platform. The device is a 21‑electrode, gel‑free headset designed for short‑term, up‑to‑2.5‑hour recordings in outpatient clinics and patients’ homes. Integrated with Zeto’s cloud and...
FDA Clears Low-Dose MRI Contrast Agent Vueway for Newborns and Infants
The U.S. Food and Drug Administration has granted an expanded indication for Bracco's Vueway (gadopiclenol) injection, allowing its use in neonates and infants for contrast‑enhanced MRI. The macrocyclic agent delivers high‑quality images at half the standard gadolinium dose (0.05 mmol/kg), addressing...
Dual-Eligible Patients Fall Through the Cracks in Substance Use Disorder Treatment
Dual‑eligible Americans—about 12 million who receive both Medicare and Medicaid—face stark gaps in substance‑use disorder (SUD) treatment. Roughly 1.5 million of these high‑need patients have SUD, yet Medicaid covers only about half of guideline‑recommended services and Medicare’s recent outpatient expansion omits telehealth...
Shooting People In The Head and Heart with mRNA Vaccines, Murder One or Insanity?
A recent blog post dramatizes a WHO‑backed Global Vaccine Data Network (GVDN) study that examined 99 million vaccine recipients across eight countries. The study confirmed strong myocarditis and pericarditis signals after mRNA COVID‑19 vaccines, while Guillain‑Barré syndrome and cerebral venous sinus...
Why Clinical Listening Skills Outpace Artificial Intelligence
A new national survey by Littmann Stethoscopes shows that 92% of clinicians consider listening the first step in diagnosis, and nearly nine in ten have identified a critical condition solely through auscultation. However, 73% say time pressure and rising patient...
Cervical Disc Replacement vs Cervical Fusion: Which Wins the Back to Work Race?
A new Level I systematic review and meta‑analysis of 16 randomized trials (5,657 patients) compares anterior cervical discectomy and fusion (ACDF) with cervical disc replacement (CDR) on return‑to‑work (RTW) outcomes. CDR patients are 1.33‑1.58 times more likely to be back...
Regenerative Healthcare by Design: Engineering Health-Centric Buildings and Urban Ecosystems
Regenerative health ecosystems are redefining healthcare by embedding health‑optimizing systems into buildings and cities. These health‑centric environments combine renewable energy, AI‑driven interior controls, and biophilic design to continuously support human physiology and cognition. A sophisticated engineering stack—physical AI, blockchain, autonomous...
WSJ's Editorial Board Contradicts What Its Newsroom Has Reported on Medicare Advantage
The Wall Street Journal’s editorial board defended Medicare Advantage even as its own newsroom revealed a $50 billion overbilling scheme and MedPAC projected $76 billion in overpayments for 2026. The editorial relies on an industry‑funded study to claim cost savings, while reporters...
Parents Are Turning to ‘Vaccine-Friendly’ Pediatricians Who Will ‘Simply Answer Questions’
The post reports a surge in demand for “vaccine‑friendly” pediatricians as parents seek doctors who will answer questions and accommodate delayed or skipped immunizations. Texas doctor Osvaldo Villarreal and Florida pediatrician Brian Thornburg cite rapid practice growth and multi‑year waitlists...
How to Master the Pharmacovigilance System Master File for Inspection Readiness
Mastering the Pharmacovigilance System Master File (PSMF) is essential for inspection readiness, as regulators use it to gauge a company’s PV compliance before any formal interview. In the EU and UK, the PSMF must be supplied within seven days of...
Health Care Startups Desperately Need Clinical Expertise
Health‑care venture capital continues to pour money into startups designed by technologists rather than clinicians, creating products that clash with established workflows. Dr. Harsha Moole argues that physician‑scientists bring a structural advantage by vetting opportunities through three gates—clinical necessity, regulatory feasibility,...
Verastem Oncology Announces Two-Year Median Follow-Up Data on AVMAPKI® FAKZYNJA® Combination Therapy (Avutometinib Capsules; Defactinib Tablets) in Recurrent Low-Grade Serous...
Verastem Oncology presented two‑year median follow‑up data from its Phase 2 RAMP 201 trial of the AVMAPKI® FAKZYNJA® combination (avutometinib + defactinib) in recurrent low‑grade serous ovarian cancer (LGSOC). The updated analysis confirmed a median duration of response of 31.1 months and a median progression‑free survival...
How Expiring ACA Enhanced Premium Tax Credits Hurt Business
The expiration of the ACA’s enhanced premium tax credits has forced self‑employed entrepreneurs to see their monthly health‑insurance costs jump from zero to $2,300, dramatically tightening household budgets. In 2025, more than 4.4 million of the 5.2 million small‑business owners who relied...
Lessons From HIMSS: AI Will Not Fix Healthcare: Informed Leadership Might
At HIMSS 2026, industry leaders acknowledged that AI is no longer a future possibility but a present reality in healthcare, with over 1,200 AI‑enabled medical devices already in use in the United States. However, the rapid pace of adoption has...
Bial Launches Education and Awareness Campaign for World Parkinson’s Day
Bial, the Portuguese biopharma focused on neuroscience, has launched “Dialogues with Parkinson’s,” a year‑long education campaign in partnership with Parkinson’s Europe. The initiative aims to improve communication among patients, caregivers and clinicians to promote earlier diagnosis, especially for the 10‑20%...
NVIDIA Just Helped Map 31 Million Protein Complexes and the Health Tech Investment Implications Are Enormous
NVIDIA, DeepMind, EMBL‑EBI and Seoul National University expanded the AlphaFold Protein Structure Database to include 31 million predicted protein complexes—23.4 million homodimers and 7.6 million heterodimers—across 4,777 proteomes. Using H100 DGX Superpod clusters, MMseqs2‑GPU and TensorRT‑accelerated inference, the team generated 1.8 million high‑confidence homodimer...
From Arsenic in Antifreeze to a Single Pill
Human African trypanosomiasis, or sleeping sickness, once required melarsoprol—an arsenic‑based injection that killed the parasite but caused severe brain reactions and a 5% mortality rate. In 2024 the European Medicines Agency approved acoziborole, a single‑dose oral therapy with a 96%...
The Deadly Labyrinth of Nigerian Healthcare
Gazelle Mba’s personal narrative reveals chronic failures in Nigeria’s health system, from absent ambulances and ID‑driven triage to under‑trained staff performing risky procedures. Her mother survived a bus crash and a botched kidney‑stone surgery that caused a total spinal block,...
Secretary Kennedy Takes Health Tour to Arizona Indian Country
Secretary of Health and Human Services Robert F. Kennedy Jr. delivered a keynote and fireside chat at the Tribal Self‑Governance Conference in Chandler, Arizona, spotlighting the alarming rise in diabetes among the Pima Tribe. He announced a $1 billion infrastructure allocation...
Veeva V. Epic: Kicking the Can in Dane County
Veeva filed a robust opposition to Epic Systems’ motion to dismiss, targeting the enforceability of Epic’s equity clawback, non‑compete provisions, and arbitration clauses. The response leaned heavily on a Wisconsin "in terrorem" theory, arguing that the clawback itself deters competition...
Weekly Neuroscience Update
A wave of neuroscience research highlights non‑drug therapies and genetic insights that could reshape treatment for mental health, cancer‑related cognitive issues, and metabolic disorders. Transcranial magnetic stimulation shows lasting reduction of PTSD fear responses, while electroacupuncture improves cognition and alleviates...
A NICE-Approved Treatment for 8 Million People that Fewer than 0.5% of Clinicians Offer
A new health‑tech model is delivering a NICE‑approved therapy to roughly 8 million UK patients who currently lack access, as fewer than 0.5% of clinicians prescribe it. The approach bypasses traditional hospital pathways, offering direct‑to‑consumer (DTC) prescribing and remote monitoring. Early...
The Hidden Clinical Cost of HCC Coding in Primary Care
Hierarchical condition category (HCC) coding, intended for Medicare Advantage risk adjustment, now interrupts primary‑care visits with electronic alerts demanding physicians verify dozens of diagnoses. The workflow intrusion adds significant time to typical 15‑minute appointments, pulling clinicians away from patient interaction...
NPPA Gene Therapy to Encourage Greater Regeneration Following Heart Attack
Researchers at Columbia Engineering have engineered an RNA‑lipid nanoparticle that programs skeletal muscle to secrete a pro‑ANP precursor, which the heart‑specific enzyme Corin converts into active atrial natriuretic peptide. This two‑phase gene‑therapy bypasses the need for direct cardiac drug delivery,...
Cleveland Clinic Catalyzer Program Awards $250K to Quantum Startups
Cleveland Clinic’s Quantum Innovation Catalyzer Program will award up to $250,000, matched with in‑kind resources, to three startups applying quantum computing to health challenges. The selected firms—EntangleBio, Polaris Quantum Biotech, and Singularity Quantum—gain access to IBM’s Quantum System One, the...
Daraxonrasib (RMC-6236): The 2025 Molecule of the Year
Revolution Medicines’ daraxonrasib (RMC‑6236) was crowned 2025 Molecule of the Year after winning 50% of community votes. The oral, tri‑complex molecular glue inhibitor uniquely targets the active GTP‑bound state of KRAS, NRAS and HRAS, covering both mutant and wild‑type isoforms....
UK Cancer Trial Targets Difficult-to-Treat Tumours in Children
A new CAR T‑cell immunotherapy trial, called Mighty, will enroll up to 60 children and young adults with hard‑to‑treat solid tumours in the UK and US. The study targets rhabdomyosarcoma, Ewing sarcoma and soft‑tissue sarcoma, cancers that behave differently from...
Will the MAHA Movement Save the GOP This Fall — or Help Bury It? This Man May Be Key
Tony Lyons, chief strategist of the Make America Healthy Again (MAHA) movement, has urged Republican leaders to adopt popular health‑focused policies—such as banning soda from SNAP benefits and eliminating artificial food dyes—to win the 2026 midterm elections. In a February...
Tracing the Decline in American Heart Disease Mortality
U.S. heart disease deaths slipped to 915,973 in 2023, a modest decline from 2022, while the age‑adjusted mortality rate dropped to 218.3 per 100,000. The reduction reflects fewer sudden heart attacks, yet deaths from chronic conditions such as heart failure...